首页|阿加曲班联合阿司匹林对急性脑梗死溶栓后患者凝血指标及神经功能的影响

阿加曲班联合阿司匹林对急性脑梗死溶栓后患者凝血指标及神经功能的影响

扫码查看
目的 探究阿加曲班联合阿司匹林对急性脑梗死(ACI)溶栓后患者的应用价值.方法 选择 2021年 12月—2023 年12 月莘县中心医院收治的 90 例ACI患者为研究对象,按随机数字表法将其分为对照组和观察组,各 45 例.对照组采用阿司匹林治疗,观察组在对照组基础上加用阿加曲班治疗,两组均持续治疗 7d.比较两组的临床疗效、凝血指标、神经功能、日常生活能力和不良反应发生情况.结果 观察组治疗总有效率为 91.11%,高于对照组的 73.33%,差异有统计学意义(P<0.05).治疗后,观察组纤维蛋白酶原水平低于对照组,血浆凝血酶、凝血酶原及部分凝血酶原时间均长于对照组,组间差异有统计学意义(P<0.05);观察组美国国立卫生研究院卒中量表评分低于对照组,Barthel指数量表评分高于对照组,组间差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 阿加曲班联合阿司匹林在治疗ACI溶栓后患者中的疗效确切,可改善患者的神经功能和凝血功能,提升其日常生活能力,且安全可靠.
Effect of Agatroban Combined with Aspirin on Coagulation Indicators and Neurological Function in Patients with Acute Cerebral Infarction after Thrombolysis
Objective To explore the application value of agatroban combined with aspirin in patients with acute cerebral infarction(ACI)after thrombolysis.Methods A total of 90 ACI patients admitted to Shen County Central Hospital from December 2021 to December 2023 were selected as the research object,and divided into a control group and an observation group according to random number table method,with 45 cases in each group.The control group was treated with aspirin,and the observation group was treated with agatroban on the basis of the control group,both groups were treated continuously for 7 days.The clinical efficacy,coagulation indicators,neurological function,daily living ability and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 91.11%,which was higher than 73.33%of the control group,and the difference was statistically significant(P<0.05).After treatment,the level of fibrinogen in observation group was lower than that in control group,and the plasma thrombin,prothrombin and partial prothrombin time were longer than that in control group,the differences between the groups were statistical significance(P<0.05);the score of the National Institutes of Health Stroke Scale in the observation group was lower than that in the control group,and the score of the Barthel Index scale was higher than that in the control group,the differences between the groups were statistical significance(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Agatroban combined with aspirin is effective in the treatment of patients after thrombolytic ACI,can improve the neurological function and coagulation function of patients,enhance their daily life ability,and is safe and reliable.

Acute cerebral infarctionAgatrobanAspirinCoagulation indicatorsNeurological function

王国强、李鑫

展开 >

莘县中心医院神经内二科,山东 聊城 252400

聊城市第四人民医院心身医学科,山东 聊城 252000

急性脑梗死 阿加曲班 阿司匹林 凝血指标 神经功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(14)